- Home
- CLPT vs TYRA Comparison
CLPT vs TYRA Comparison
Compare CLPT & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- TYRA
- Stock Information
- Founded
- CLPT 1998
- TYRA 2018
- Country
- CLPT United States
- TYRA United States
- Employees
- CLPT N/A
- TYRA N/A
- Industry
- CLPT Medical/Dental Instruments
- TYRA Biotechnology: Pharmaceutical Preparations
- Sector
- CLPT Health Care
- TYRA Health Care
- Exchange
- CLPT Nasdaq
- TYRA Nasdaq
- Market Cap
- CLPT 742.2M
- TYRA 681.7M
- IPO Year
- CLPT N/A
- TYRA 2021
- Fundamental
- Price
- CLPT $27.32
- TYRA $14.98
- Analyst Decision
- CLPT Strong Buy
- TYRA Strong Buy
- Analyst Count
- CLPT 3
- TYRA 7
- Target Price
- CLPT $27.67
- TYRA $30.71
- AVG Volume (30 Days)
- CLPT 1.8M
- TYRA 162.7K
- Earning Date
- CLPT 11-06-2025
- TYRA 11-06-2025
- Dividend Yield
- CLPT N/A
- TYRA N/A
- EPS Growth
- CLPT N/A
- TYRA N/A
- EPS
- CLPT N/A
- TYRA N/A
- Revenue
- CLPT $33,593,000.00
- TYRA N/A
- Revenue This Year
- CLPT $22.34
- TYRA N/A
- Revenue Next Year
- CLPT $25.50
- TYRA N/A
- P/E Ratio
- CLPT N/A
- TYRA N/A
- Revenue Growth
- CLPT 19.68
- TYRA N/A
- 52 Week Low
- CLPT $9.76
- TYRA $6.42
- 52 Week High
- CLPT $30.10
- TYRA $29.60
- Technical
- Relative Strength Index (RSI)
- CLPT 69.07
- TYRA 63.79
- Support Level
- CLPT $23.47
- TYRA $14.28
- Resistance Level
- CLPT $30.10
- TYRA $15.60
- Average True Range (ATR)
- CLPT 2.57
- TYRA 0.70
- MACD
- CLPT -0.33
- TYRA 0.08
- Stochastic Oscillator
- CLPT 72.03
- TYRA 76.34
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.